Comparative drug release data for all formulations
COMPARATIVE STUDY ON THE DISSOLUTION PROFILES OF COMMERCIAL MODIFIED RELEASE FORMULATIONS OF NIFEDIPINE
... blood drug concentrations at steady state, respectively and C ssav is average blood drug oncentration at steady ...DISCUSSION All the products were found to contain the labeled amounts of the ...
16
PREPARE AND EVALUATE MUCOADHESIVE FORMULATIONS OF LAMIVUDINE WITH BETTER CONTROLLED/ SUSTAINED DRUG RELEASE PROFILE
... oral drug delivery 10 ...different formulations and polymers have been ranked as more or less mucoadhesive by using randomly chosen methods 12-16 ...different formulations involving a large variety ...
7
Lack of Pediatric Drug Formulations
... such comparative studies in children. FUNDING IN RESEARCH When a new drug is marketed for adults, the man- ufacturer generally has little interest in supporting research on developing a liquid formation for ...
5
Development and validation of In Vitro – In Vivo Correlations for the developed modified release formulations of selected drug candidates.
... B. De Spiegeleer and coworkers 38 have reported dissolution stability and IVIVC investigation of a buccal tablet. Using a recently developed bending point criterion to describe certain dissolution profiles, a physical ...
236
Controlled release tablet formulations of carvedilol
... tablet formulations of CAR were prepared by direct compression method, as per formulae given in Table ...as release retardant ...each. All the ingredients were passed through sieve # 80 before ...
9
COMPARATIVE STUDY OF DIFFERENT FORMULATIONS OF ACECLOFENAC AS A TOPICAL DRUG DELIVERY SYSTEM AND IT’S IN VITRO AND IN VIVO CHARACTERIZATION
... topical formulations using various dermatological bases and to evaluate release properties and improved stability throughout its shelf ...topical formulations were formulated and characterized for ...
8
Photoactivable heterocyclic cages in a comparative release study of butyric acid as a model drug
... ºC. All chemical shifts are given in ppm using δ H Me 4 Si = 0 ppm as reference and J values are given in ...spectrofluorometer. All reagents were used as ...
28
COMPARATIVE IN VITRO DRUG RELEASE STUDIES OF GLIMEPIRIDE SOLID DISPERSIONS & METFORMIN MICROCAPSULES
... Glimepiride is rapidly absorbed by the liver after oral administration. It undergoes extensive first pass metabolism in the liver. It is practically insoluble in water and other aqueous media. The very poor aqueous ...
7
Input estimation for extended release formulations exemplified with exenatide
... In parametric methods, a model is constructed for the absorption process, which can be difficult when the absorption has a complicated profile. Here, we place emphasis on non-parametric methods that avoid making strong ...
13
PREFORMULATION STUDIES OF CONTROLLED/SUSTAINED RELEASE FORMULATIONS: AN OVERVIEW
... which all contribute of compression characteristics of ...a drug substance as it relates to pharmaceutical processing is desirable during its Preformulation evaluation especially when the active ingredient ...
5
DEVELPOMENT AND EVALUATION OF SUSTAINED RELEASE FORMULATIONS OF VENLAFAXINE HYDROCHLORIDE
... model drug which is a ...retardants. All the precompressional parameters were found to be within the standard ...thickness, drug content, in-Vitro release, swelling and stability ...on ...
10
Oral mucoadhesive microcarriers for controlled and extended release formulations
... L - 51 firstly attached to the sample of tissue; magnetic force was then generated by an electromagnet mounted on the microscope vertically above the tissue chamber. The position of microcarrier was determined by ...
19
DISSOLUTION ENHANCEMENT AND COMPARATIVE ASSESSMENT OF MICROCAPSULE LOADED SUSTAINED RELEASE MUCOADHESIVE GASTRO RETENTIVE TABLETS WITH AVAILABLE MARKETED FORMULATIONS
... novel drug delivery system and conventional delivery ...sustained release formulation of this above mentioned drug will definitely be able to provide better therapeutic efficacy, lower the dosing ...
6
Comparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with attention deficit/hyperactivity disorder
... of data from two similarly designed, large, randomized, placebo-controlled trials showed that OROS-MPH has similar efficacy and tolerability as that of IR-MPH administered three times per ...
8
Comparative <em>in vivo</em> bioequivalence and <em>in vitro</em> dissolution of two valproic acid sustained-release formulations
... acid formulations (three 200 mg tablets of Depakene R or Selenica R) were administered in a randomized crossover fashion with a washout period of at least ...different drug sequences: Depakene R-Selenica R ...
6
Review of extended-release formulations of Tramadol for the management of chronic non-cancer pain: focus on marketed formulations
... extended-release formulations available in Canada and the United States – namely Zytram XL, Ralivia/Ultram ER, Tridu- ral, and Durela/ConZip – have all been individually reported to possess similar ...
13
A COMPARATIVE STUDY OF TERBINAFINE ETHOSOMAL FORMULATIONS : A NOVEL APPROACH
... the Comparative investigation was carried out for ex vivo skin permeation, ex vivo drug release and entrapment efficiency ...studies. Drug release followed zero order release ...
7
Pharmacological and clinical evidence of nevirapine immediate- and extended-release formulations
... Recent data show that nevirapine used as single dose for the prevention of perinatal HIV-1 transmission is a risk factor for emergence of HIV-1–resistant mutations that reduce efficacy of nevirapine- based ...
11
Mathematical Modeling for Pharmacokinetic Predictions from Controlled Drug Release NanoSystems: A Comparative Parametric Study
... simulating drug release kinetics are compared using available experimental data sets obtained in real systems with different drugs and nano-sized ...in drug(s) release, and (ii) ...
6
Abuse and Diversion of Immediate Release Opioid Analgesics as Compared to Extended Release Formulations in the United States
... Program data are spontaneously reported, and represent a subset of all possible ...the Drug Diversion Program represents only a small portion of all nationwide diversion ...of all of ...
14